Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Larval therapy versus hydrogel for leg ulcer debridement
2011-001284-44Phase 3Completed
- Sponsor
- Maggot 2006
- Start
- Apr 2011
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of MedLarv in stasis ulcer and Mixed venous-arterial leg ulcer (MVALU) (2 arms), sponsored by Maggot 2006. Primary endpoint: Ulcer clearing after larval therapy. Started Apr 2011; status: completed.
02
Drugs
MedLarv
03
Conditions
stasis ulcerMixed venous-arterial leg ulcer (MVALU)
Beyond the preview
Go deeper on 2011-001284-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001284-44.